Skip to main content
. Author manuscript; available in PMC: 2024 Feb 26.
Published in final edited form as: Cardiovasc Revasc Med. 2021 Sep 30;39:101–105. doi: 10.1016/j.carrev.2021.09.007

Fig. 2.

Fig. 2.

Trend of Reported MitraClip associated fatal events (expressed as a percentage of all reported events) reported to the United State Food and Drug Administration [FDA] Manufacturer and User Facility Device Experience [MAUDE] database for MitraClip, 2014–2020.